Polycystic ovary syndrome dependency on mtDNA mutation; copy Number and its association with insulin resistance

BMC Research Notes

Table 1 Clinical and metabolic features of PCOS-IR patients and control subjects Characteristics

P	PCOS-D (n = 32)		PCOS-ND (n = 38)		NPCOS-D (n = 34)		HC (n = 25)
P	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Age (y)	24.76	3.91	24.99	3.23	25.35	4.52	25.30	4.47
FSH (IU/L)	4.73	1.72	5.93	1.42	4.95	3.10	5.53	3.07
LH (IU/L)**	9.19	6.17	9.30	5.09	7.30	8.79	6.20	8.70
LH/FSH**	1.59	0.89	1.26	0.74	1.91	0.72	0.90	0.71
PRL (μg/L)	16.12	54.37	16.80	44.89	13.78	14.29	13.75	14.15
E2 (pmol/L)	198.46	51.36	157.51	42.40	199.58	94.18	220.35	93.23
PRGE (nmol/L)	2.34	1.36	1.85	1.12	1.96	0.88	1.95	0.87
TT (nmol/L)**	2.44	0.41	1.94	0.34	2.33	0.45	1.33	0.45
Insulin (0 h) (μU/mL)**	13.58	6.94	10.77	5.73	15.92	1.46	5.91	1.45
Glucose (0 h) (mmol/L)	4.37	1.29	3.47	1.06	4.71	0.54	4.70	0.53
HOMA-IR**	3.23	1.86	2.05	1.53	3.38	0.36	1.38	0.36

Group I had 32 diabetic women’s with PCOS syndrome (PCOS-D), Group II, includes 38 non diabetic PCOS (PCOS-ND) women, Group III includes 34 Diabetic women but non-PCOS (NPCOS-D). Additionally, 25 age and BMI-matched healthy control (HC) participants were recruited

ISSN: 1756-0500